Fundraising

In a tough fundraising market, an opportunity to add a new and very rich pool of retirement savings as a capital source is enticing for private equity GPs, especially the very largest.

High River Resources II’s limited partners include institutional investors, registered investment advisors, and family offices.

Pacific Equity Partners recently closed its seventh flagship fund on a company-record A$3.2bn, securing several new LPs in the process – and it led fundraising internally.

Glade Brook Strategic Growth Fund IV is focused on growth equity investments in early-, mid- and late-stage tech companies.

Buyouts' North American fundraising data suggests a sustained drop in fund closings over 2022-23 might have leveled off somewhat last year and in H1 2025.

The mid-market GP is targeting a $2.75bn raise for Fund IV, having recently exceeded the target on its predecessor.

The fund’s investor base includes public and private pension funds, insurance companies, foundations, family offices and high-net worth clients globally.

Oak Hill’s Fund VII is part of a series that goes back to 1999, when the GP, the one-time family office of US billionaire businessman Robert Bass, raised its first outside capital.

Trident X is approximately $2.5 billion larger than Trident IX, a $9 billion fund, which closed in 2022.

The state of play across private markets fundraising. Plus: US fund managers want more ESG leeway from their European LPs; and Leonard Green is back in the market with its 10th buyout flagship. Here's today's brief, for our valued subscribers only.